Multiple Sclerosis Trial Exhibits Positive Results of Stem Cell Therapy.

A five year phase II clinical trial has shown initial success in treating multiple sclerosis.

In a recent update of an ongoing five year clinical trial conducted by the Chicago Blood Cancer Institute, patients with relapsing-remitting multiple sclerosis have experienced suppression of disease-related inflammation as a result of hematopoietic stem cell transplantations.  The stem cells have the ability to regulate the autoimmune attack on the central nervous system, and have provided 82.8% of the patients with two years thus far of event-free disease remission. Continue reading

Lupus Therapy Incorporates Mesenchymal Stem Cells

Beijing researchers are capitalizing on the abilities of mesenchymal stem cells to reduce inflammation and promote cell growth to combat systemic lupus erythematosus.

In a recent clinical study conducted in Beijing, researchers are testing a treatment for patients suffering from systemic lupus erythematosus by administering autologous [the patient’s own] mesenchymal stem cells.  The researchers aim to capitalize on the unique abilities of MSCs to not only differentiate into a multitude of different cell types, but to reduce the autoimmune attack in patients affected by lupus as well. Continue reading

Multiple Sclerosis Therapy Incorporates Stem Cells in Clinical Trial

Mesenchymal Stem Cell Therapy has been deemed safe for patients suffering from multiple sclerosis.

A recent clinical trial conducted by the University of Genoa has determined that mesenchymal stem cell therapy to treat multiple sclerosis is indeed safe to perform on humans.  27 MS patients completed the study, which comprised an injection of the patient’s own [autologous] mesenchymal stem cells [MSCs] to reduce excessive inflammation caused by the patients’ own immune systems. None of the patients suffered any side effects from the injection. Continue reading

Multiple Sclerosis Therapy Incorporates Stem Cells in Clinical Trial

Mesenchymal Stem Cell Therapy has been deemed safe for patients suffering from multiple sclerosis.

A recent clinical trial conducted by the University of Genoa has determined that mesenchymal stem cell therapy to treat multiple sclerosis is indeed safe to perform on humans.  27 MS patients completed the study, which comprised an injection of the patient’s own [autologous] mesenchymal stem cells [MSCs] to reduce excessive inflammation caused by the patients’ own immune systems. None of the patients suffered any side effects from the injection. Continue reading

New York Times: The Eruption of Stem Cell Therapies.

Mr. Edgar Irastorza is one of thousands of people already benefiting from the progression of stem cell based therapies.

As reported on the front page of the New York Times Science section, clinical applications of stem cell based therapies are accelerating at a rate that will revolutionize the medical field in a matter of years.  In the United States alone, there are currently over 4000 therapies in clinical trials for the treatment of heart disease, blindness, spinal cord injuries, diabetes, H.I.V., and other diseases, injuries, and traumas. Continue reading

Vaginal Implants Grown Utilizing Autologous Stem Cells

Stem Cells were utilized to create lab-engineered vagina implants for patients suffering from MRKH syndrome.

Researchers from the Wake Forest Baptist Medical Center’s Institute for Regenerative Medicine have successfully grown and implanted vaginal organs into four teenage girls born with MRKH Syndrome, a rare condition in which the vagina is undeveloped. The scientists extracted the patient’s own stem cells and placed them onto a biodegradable scaffold of a vagina.  The scaffolds were then implanted into the patient’s pelvis, and gradually the stem cells differentiated into a permanent, functional vagina. Continue reading

Lou Gehrig’s Disease Treatment Utilizing Stem Cells Advances

The clinical trial utilizing stem cells can lead to advances in both treating and preventing Lou Gehrig’s disease.

A team of researchers from the University of Michigan and the University of Emory reported positive results from a phase 1 clinical study utilizing stem cells to treat amyotrophic lateral sclerosis [ALS], Lou Gehrig’s disease.  In addition to verifying the safety of the new procedure, the trial revealed some progress in preventing further disease damage to the motor nerves by improving their cellular environment. Continue reading

Lower Back Pain Relieved by Mesenchymal Stem Cells [MSCs]

MSC’s injected into the spine caused a decrease in back pain and the need for invasive treatment.

In a recent Phase II clinical study, researchers report that mesenchymal stem cells were successful in relieving chronic lower back pain. The scientists injected MSCs directly into the degenerating vertebral disks of patients suffering from lower back pain, resulting in an overall reduction in the mean pain score, improved function for at least 12 months, and a reduced need for further surgical and non-surgical treatment interventions.

Of the 6 million Americans suffering from debilitating back pain today, 3.5 million are affected by degenerative invertebral disk disease. The results of this clinical trial show that, instead of addressing the symptoms, mesenchymal stem cells are able to treat the source of the pain for long lasting relief. According to lead researcher, Dr. Tory McJunkin, M.D, “This study shows we are progressing toward major advances in pain medicine,”

Mesenchymal stem cells have the unique capacity to regenerate a multitude of different types of tissues – such as neurons, insulin producing pancreatic beta cells, bone, cartilage, and cardiomyocites amongst them. This Phase II study is just one example of the utility of stem cells in successfully treating conditions previously thought to be untreatable or treatable only through invasive options. To learn how to bank your own valuable stem cells to insure access to emerging regenerative therapies, visit www.stemsave.com or call 877-783-6728 877-StemSave) today.

 

Spinal Cord Injury Stem Cell Treatment Enters Clinical Trials.

A new treatment aims to treat spinal cord injuries by injecting stem cells into the spinal cord.

A medical team from the University of Calgary is now recruiting candidates to participate in the phase one clinical trial for a new stem cell therapy that aims to treat spinal cord injuries.  The researchers plan to inject stem cells into the spinal cord two sites above and two sites below the point of injury to recreate lost or damaged tissue. Continue reading

Bone Reconstruction Technique Utilizes Autologous Stem Cells

Stem cells are allowing doctors to personalize treatments to repair damaged or diseased bone.

A team of medical researchers at Saint Luc University Clinic have developed a method of repairing bones utilizing autologous [the patient’s own] stem cells.  The process involves harvesting the stem cells from the patient, differentiating the stem cells in-vitro to grow bone, pairing the cells with a scaffolding matrix and then molding the material to repair damaged or diseased bone within the patient. Continue reading